Chinese authorities have greenlit a clinical trial for the world's first tetravalent vaccine against norovirus, the most common cause of viral gastroenteritis. The vaccine, after four years of development, can theoretically prevent 80 to 90 percent of norovirus infections...
Chinese scientists will conduct the second-phase clinical trial of a new drug to treat lupus, an autoimmune disease, the Chinese Academy of Sciences (CAS) said. The new drug SM934 is a water-soluble artemisinin derivative developed by researchers with the Shanghai Institu...